Ibl Healthcare Limited · PSX:IBLHL

Ibl Healthcare — Investor Presentation (2022)

18 slides from Ibl Healthcare's investor presentation, 2022

  1. Slide 1: ING

    ING i EFFICIENCY

  2. Slide 2: Company's Overview, Financial Highlights, Future Outlook, Q&A

    Company’s Overview Financial Highlights Future Outlook Question & Answers

  3. Slide 3: Company's Overview

    Tine 1 Lit... FIEALTHCARESE A SEARLE Supsiaiay

  4. Slide 4: Company background

     Incorporated as Private Limited company in July 1997.  In November 2008 share were listed on Pakistan Stock Exchange.  IBL HealthCare is a subsidiary of The Searle Company Limited.  The Company has cumulative growth of 22% in last five-years

  5. Slide 5: Partner brands

    Meadjoh ». € Nes aa Health ay WHOLE ORE - estle Science ¥ EARTH HEALTH » HYGIENE » HOME BAUSCH +LOMB i&K LN ° -—— See better. Live better. Ser KAMnsom principle WEGOH ES TOP QUALITY, TOP EFFICIENCY

  6. Slide 6: Healthcare

    HEALTHCARE Medical Lifestyle Nutritior Nutrition NUTRITION - = ge Pharma Renal Critical Medica Blood Vv MEDICAL DISPOSABLES --------------------- Gre Ars Gloves Transfusion Administration ns General O- PHARMAGEUTIGAL ———------ >= Gastroenterology hee @mamieay Urology

  7. Slide 7: Healthcare

    HEALTHCARE cane crm | CUD faz m \cx = Sy 3 ae weg wR Prei-up

  8. Slide 8: Health and Wellness

    SV HEALTH AND WELLNESS HEALTHCARE ‘SEARLE @ a i = i> y HUITAMINE) MEDICAL DISPOSABLES

  9. Slide 9: Financial Highlights

    Financial Highlights

  10. Slide 10: Five Years Performance & Future Target

    Five Years Performance & Future Target OPERATING RESULTS 4,500,000 4,000,000 3,500,000 3,000,000 REVENUE IN '000 2,500,000 2,000,000 1,500,000 1,000,000 500,000 - 2017-18 2018-19 2019-20 2020-21 2021-22 2022-23 Revenue 1,358,297 1,584,972 2,664,604 3,003,909 3,651,125 4,176,717 Profit After Tax 149,

  11. Slide 11: Profit & Loss FY 2021-22

    Profit & Loss FY 2021-22 (in PKR ‘000) Jun-22 Jun-21 Growth % 3,651,125 3,003,909 22% Net sales 1,256,237 1,022,496 23% Gross Profit 570,691 406,772 40% Profit from operations 302,859 300,488 1% Profit for the year 34% 34% Gross Profit %

  12. Slide 12: Future Outlook

    Future Outlook

  13. Slide 13: Canderel

    Canderel Naturally Sweet

  14. Slide 14: Naturally Sweet

    Naturally Sweet … • Canderel is now available in Stevia in three different variants • 60g Jar, Tablets, and Sachets • Canderel Stevia brings you natural and zero calorie sweetness • Enjoy the guilt-free sweetness

  15. Slide 15: Medisana

    Medisana One of the leading German brand of Medical devices since 1982 It has various products in its portfolio including BP Monitors, Pulse Oximeter, Massaging goods, Weighing scales, Glucometers and various others German brand award for “Brand Strategy-B 2 C”

  16. Slide 16: Product Range for Launch

    Product Range for Launch Upper Arm-BP Monitor Wrist BP Monitor Diagnostic Weighing Scale Bathroom Scale Thermometer Pulse Oximeter Glucometer Air Humidifier

  17. Slide 17: Question & Answers

    Question & Answers

  18. Slide 18: Thank You

    Thank You Find us on iblhc.com/ linkedin.com/company/ibl-healthcare-ltd facebook.com/Iblhealthcare instagram.com/iblhealthcarelimited

IBL HealthCare — Investor Presentation (2022) on 6ix